Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 USD | -6.15% | -7.18% | -6.23% |
Business Summary
Number of employees: 91
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Specialty Pharmaceutical Products
100.0
%
| 42 | 100.0 % | 40 | 100.0 % | -5.85% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
97.2
%
| 41 | 96.4 % | 38 | 97.2 % | -5.08% |
Non-United States
2.8
%
| 2 | 3.6 % | 1 | 2.8 % | -26.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
John Hamm
DFI | Director of Finance/CFO | 67 | 18-12-31 |
James Herman
CMP | Compliance Officer | 67 | 02-12-31 |
Director/Board Member | 72 | 99-01-05 | |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
Chris Bitterman
SAM | Sales & Marketing | 58 | 17-12-31 |
Kenny Acevedo
SAM | Sales & Marketing | - | 10-12-31 |
Adam Mostafa
PRN | Corporate Officer/Principal | 44 | 16-12-31 |
Cindy Patton
SAM | Sales & Marketing | - | 08-12-31 |
Tan Cheow Choon
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Brown
BRD | Director/Board Member | 59 | 22-07-14 |
A. Kazimi
CEO | Chief Executive Officer | 65 | 99-01-06 |
Ken Krogulski
BRD | Director/Board Member | 66 | 17-01-17 |
Joseph Galante
BRD | Director/Board Member | 74 | 18-09-18 |
Director/Board Member | 72 | 99-01-05 | |
James Jones
BRD | Director/Board Member | 76 | 09-12-31 |
Caroline Young
BRD | Director/Board Member | 49 | 16-06-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,176,529 | 7,776,179 ( 54.85 %) | 0 | 54.85 % |
Company contact information
Cumberland Pharmaceuticals, Inc.
1600 West End Avenue Suite 1300
37203, Nashville
+
http://www.cumberlandpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-6.23% | 25.38M | |
+28.67% | 46.19B | |
+18.66% | 22.88B | |
+20.11% | 14.18B | |
+0.55% | 12.63B | |
+46.16% | 12.07B | |
-1.79% | 7.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.80% | 5.14B |
- Stock
- Equities
- Stock Cumberland Pharmaceuticals Inc. - Nasdaq
- Company Cumberland Pharmaceuticals Inc.